Llwytho...
HER2-targeted therapies in breast cancer
HER2 was acknowledged as an important therapeutic target in breast cancer more than twenty-five years ago. Subsequently, significant basic science and translational discoveries have resulted in the approval of four HER2-targeted therapies over the past fifteen years. This editorial discusses future...
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2013
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4161367/ https://ncbi.nlm.nih.gov/pubmed/23565676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2013.789497 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|